{"id":733,"date":"2019-05-15T08:13:20","date_gmt":"2019-05-15T06:13:20","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=733"},"modified":"2025-01-23T12:59:13","modified_gmt":"2025-01-23T11:59:13","slug":"biostatistics","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/services\/scientific-and-technical-services\/biostatistics\/","title":{"rendered":"Biostatistics"},"content":{"rendered":"\n
The Biostatistics Unit of IDIBELL\u00a0offers statistical consulting services to researchers at the IDIBELL campus, as well as to other public and private entities. Services provided range from study planning to data analysis and assistance with interpretation of the results. The department works in an integrated manner with the HUB Pharmacology Department and the UICEC platform, where it also provides support and advice regarding clinical trials within the unit. The department also offers seminars and training courses.<\/p>\n
Our mission is to provide professional statistical analysis services to clinical researchers. Our goal is to collaborate with teams in the whole research process. Not just to serve as a resource that tackles a complex analysis.<\/p>\n
<\/p>\n\t\t\t\t If you require our services please send an email to ubidi@idibell.cat <\/a>with essential information on your research project and details about your support demand.<\/p>\n See below a list of our main services:<\/p>\n <\/p>\n <\/p>\n\t\t\t\t\tEquipment<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t Biostatistics The Biostatistics Unit of IDIBELL\u00a0offers statistical consulting services to researchers at the IDIBELL campus, as well as to other public and private entities. Services provided range from study planning to data analysis and assistance with interpretation of the results. The department works in an integrated manner with the HUB Pharmacology Department and the UICEC […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":679,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-733","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2025-03-02 03:25:53","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=733"}],"version-history":[{"count":6,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/733\/revisions"}],"predecessor-version":[{"id":25201,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/733\/revisions\/25201"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/679"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n\t\t\t\t\tServices<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t
\n
\n
\nTeb\u00e9 C<\/strong>, Valls J, Satorra P, Tob\u00edas A.
\n BMC Med Res Methodol. 2020 Sep 21;20(1):235.\nImpact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol.
\nAbelenda-Alonso G, Rombauts A, Gudiol C, Meije Y, Clemente M, Ortega L, Ardanuy C, Niub\u00f3 J, Padull\u00e9s A, Videla S, Tebe C<\/strong>, Carratal\u00e0 J.
\nBMJ Open. 2020 Aug 20;10(8):e038957.\nDaptomycin plus Fosfomycin versus Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis. A Randomized Clinical Trial.
\nPujol M, Mir\u00f3 JM, Shaw E, Aguado JM, San-Juan R, Puig-Asensio M, Pigrau C, Calbo E, Montejo M, Rodriguez-\u00c1lvarez R, Garcia-Pais MJ, Pintado V, Escudero-S\u00e1nchez R, Lopez-Contreras J, Morata L, Montero M, Andr\u00e9s M, Pasquau J, Arenas MD, Padilla B, Murillas J, Jover-S\u00e1enz A, L\u00f3pez-Cortes LE, Garc\u00eda-Pardo G, Gasch O, Videla S, Hereu P, Teb\u00e9 C<\/strong>, Pallar\u00e8s N, Sanllorente M, Dom\u00ednguez M\u00c1, C\u00e0mara J, Ferrer A, Padull\u00e9s A, Cuervo G, Carratal\u00e0 J; BACSARM Trial Investigators.
\nClin Infect Dis. 2020 Jul 29:ciaa1081.\nHydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.
\nMitj\u00e0 O, Corbacho-Monn\u00e9 M, Ubals M, Tebe C<\/strong>, Pe\u00f1afiel J, Tobias A, Ballana E, Alemany A, Riera-Mart\u00ed N, P\u00e9rez CA, Su\u00f1er C, Laporte P, Admella P, Mitj\u00e0 J, Clua M, Bertran L, Sarquella M, Gavil\u00e1n S, Ara J, Argimon JM, Casabona J, Cuatrecasas G, Ca\u00f1adas P, Elizalde-Torrent A, Fabregat R, Farr\u00e9 M, Forcada A, Flores-Mateo G, Muntada E, Nadal N, Narejos S, Gil-Ortega AN, Prat N, Puig J, Qui\u00f1ones C, Reyes-Ure\u00f1a J, Ram\u00edrez-Viaplana F, Ruiz L, Riveira-Mu\u00f1oz E, Sierra A, Velasco C, Vivanco-Hidalgo RM, Sent\u00eds A, G-Beiras C, Clotet B, Vall-Mayans M; BCN PEP-CoV-2 RESEARCH GROUP.
\nClin Infect Dis. 2020 Jul 16:ciaa1009.\nUltrathin Bronchoscopy with and without Virtual Bronchoscopic Navigation: Influence of Segmentation on Diagnostic Yield.
\nDiez-Ferrer M, Morales A, Teb\u00e9 C<\/strong>, Cubero N, L\u00f3pez-Lisbona R, Padrones S, Aso S, Dorca J, Gil D, Rosell A; on behalf of the GUIBRO study group.
\nRespiration. 2019;97(3):252-258.\nA propensity-score-matched analysis of laparoscopic vs open surgery for rectal cancer in a population-based study.
\nManchon-Walsh P, Aliste L, Biondo S, Espin E, Pera M, Targarona E, Pallar\u00e8s N, Vernet R, Espin\u00e0s JA, Guarga A, Borr\u00e0s JM.
\nColorectal Dis. 2019 Apr;21(4):441-450.\nThe association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis.
\nTeb\u00e9 C<\/strong>, Mart\u00ednez-Laguna D, Carbonell-Abella C, et al.
\nOsteoporos Int. 2019;30(12):2407-2415. doi:10.1007\/s00198-019-05122-3\nFracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort.
\nMart\u00ednez-Laguna D, Teb\u00e9 C<\/strong>, Nogu\u00e9s X, et al.
\nPLoS One. 2018;13(9):e0203533. Published 2018 Sep 7. doi:10.1371\/journal.pone.0203533\nDifferential Mortality and the Excess Rates of Hip Fracture Associated With Type 2 Diabetes: Accounting for Competing Risks in Fracture Prediction Matters.
\nTeb\u00e9 C<\/strong>, Martinez-Laguna D, Moreno V, et al.
\nJ Bone Miner Res. 2018;33(8):1417-1421. doi:10.1002\/jbmr.3435\nPredictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections.
\nGomila A, Shaw E, Carratal\u00e0 J, et al.
\nAntimicrob Resist Infect Control. 2018;7:111. Published 2018 Sep 14. doi:10.1186\/s13756-018-0401-6\nEfficacy of \u03b2-Lactam\/\u03b2-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-\u03b2-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
\nGudiol C, Royo-Cebrecos C, Abdala E, Akova M, \u00c1lvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Mart\u00edn-D\u00e1vila P, Freifeld A, G\u00f3mez L, Gottlieb T, Gurgu\u00ed M, Herrera F, Manzur A, Maschmeyer G, Meije Y, Montejo M, Peghin M, Rodr\u00edguez-Ba\u00f1o J, Ruiz-Camps I, Sukiennik TC, Tebe C<\/strong>, Carratal\u00e0 J; BICAR Study Group.
\nAntimicrob Agents Chemother. 2017 Jul 25;61(8):e00164-17.\nGeriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?
\nAntonio M, Salda\u00f1a J, Carmona-Bayonas A, Navarro V, Teb\u00e9 C<\/strong>, Nadal M, Formiga F, Salazar R, Borr\u00e0s JM.
\nOncologist. 2017 Aug;22(8):934-943.\n\t\t\t\t\n
\n\t\tJudith Pe\u00f1afiel Mu\u00f1oz\n\t<\/h4>\n\n\n
\n\t\tCONTACT\n\t<\/h4>\n
\n\t\t\n\t\tBiostatistics\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tDOCUMENTS\n\t<\/h4>\n
\n\t\t\n\t\tCore Facilities Fees (pdf)\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\tREDCap Legal advice and privacy policy\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\tIntroduction to REDCapDM package (video)\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\tIntroduction to REDCapDM package (pdf)\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tTeam\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tCoordinator\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tScientific support\t\t\t\t<\/a>\n\t\t\t\t\t\tCoordinator\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\n","protected":false},"excerpt":{"rendered":"